Mitchell P. Kopin 13D and 13G filings for TFF Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-08 5:13 pm Purchase | 2024-04-29 | 13G | TFF Pharmaceuticals, Inc. TFFP | Mitchell P. Kopin | 155,589 4.990% | 155,589 (New Position) | Filing |